Skip to main content
. 2016 Apr 6;594(11):2825–2835. doi: 10.1113/JP271141

Table 1.

Summary of the major findings regarding Orai and STIM functional effects in melanocytes and melanoma

Effects of Signalling
CRAC Effects of Orai–STIM on pathways/
components Orai–STIM on migration and proteins Other functional
Cells examined identified SOCE/I CRAC proliferation invasion involved effects
Feldman et al. 2010 Malignant and non‐malignant B16BL6 mouse cells Orai1 and STIM1 SOCE is detectable and is higher in the malignant cells ND ND PKB/AKT Inhibition of mitochondrial Ca2+ buffering sensitizes melanoma cells to apoptosis
Stanisz et al. 2012 Primary human melanocytes Orai1–3, STIM1–2(Orai1 and STIM2 highest expression) SOCE and I CRAC are detectable Promote ND ND Orai1 and STIM2 promote melanin synthesis
Stanisz et al. 2014 Human melanoma Orai1–3, STIM1–2 (Orai1 and STIM2 highest expression) SOCE is detectable (no differences between melanocytes and different melanoma cell lines) Suppress Promote MITFJARID1BBrn2 Orai1 and STIM2 are highly expressed in invasive tumour fronts in human melanoma patient samples
Umemura et al. 2014 Human melanoma Orai1, STIM1 (other Orai isoforms and STIM2 not detected) SOCE is increased in invasive melanoma cell lines vs. primary melanoma cells and melanocytes Promote (minor effect) Promote ERK Orai1‐ and STIM1‐silencing resulted in fewer lung metastases
Melanocyte cell line Low Orai1 expression
Sun et al. 2014 Human melanoma Orai1, STIM1 SOCE is detectable10% FCS induces Ca2+ oscillations while Tg sustained Ca2+ entry No effect Promote (oscillatory SOCE)Suppress (sustained SOCE) Src Promotion of plasma membrane localization of MT1‐MMP and invadopodium maturation
Hooper et al. 2015 Human melanoma Orai1‐3, STIM1‐2 (Orai2, ‐3 higher expression than Orai1; STIM1 higher expression than STIM2) SOCE and I CRAC are detectable but are much lower in highly invasive melanoma cells ND Suppress Wnt5a, PKC Wnt5a regulates SOCE amplitude and melanoma invasiveness

ND, not determined. MT1‐MMP, membrane type 1 metalloprotease; Src, proto‐oncogene tyrosine‐protein kinase.